Grown Rogue International (GRUSF) Change in Working Capital (2012 - 2025)
Grown Rogue International (GRUSF) recorded quarterly Change in Working Capital of -$2131.2 billion in Q3 2025, down 312577055.81% quarter-over-quarter from $681808.0 in Q2 2025, and down 326.9% on a YoY basis from $939.2 billion in Q3 2024.
Grown Rogue International (GRUSF) Change in Working Capital (2012 - 2025) Analysis & Trends
Grown Rogue International's Change in Working Capital history runs 13 years deep, the most recent figure standing at -$2131.2 billion for Q3 2025.
- In Q3 2025, Change in Working Capital fell 326.9% year-over-year to -$2131.2 billion; the TTM figure through Sep 2025 stood at -$3070.4 billion (down 820.72% YoY), while the FY2024 annual figure was $1.4 million, up 371.64% from the prior year.
- Change in Working Capital was -$2131.2 billion for Q3 2025 at Grown Rogue International, down from $681808.0 in the prior quarter.
- In the past five years, Change in Working Capital ranged from a high of $939.2 billion in Q3 2024 to a low of -$2131.2 billion in Q3 2025.
- Historically, Change in Working Capital has averaged -$146.9 billion across 5 years, with a median of -$404466.5 in 2022.
- The sharpest annual moves came in 2022 and 2025: Change in Working Capital jumped 52.88% in 2022, then plunged 371.19% in 2025.
- A 5-year view of Change in Working Capital shows it stood at -$286562.0 in 2021, then declined by 23.54% to -$354028.0 in 2022, then sank by 144966399.82% to -$513.2 billion in 2023, then tumbled by 83.01% to -$939.2 billion in 2024, then slumped by 126.9% to -$2131.2 billion in 2025.
- The last three Change in Working Capital figures came in at -$2131.2 billion (Q3 2025), $681808.0 (Q2 2025), and -$2.0 million (Q1 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -617.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 215.05 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | - |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | - |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | - |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | - |
| 10 | Grown Rogue International | - | - | 3.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -2,131.17 Bn |
| Sep 30, 2025 | -2,131.17 Bn |
| Jun 30, 2025 | 681,808.00 |
| Jun 30, 2025 | 681,808.00 |
| Mar 31, 2025 | -1.99 Mn |
| Mar 31, 2025 | -1.99 Mn |
| Dec 31, 2024 | -939.24 Bn |
| Dec 31, 2024 | -939.24 Bn |
| Sep 30, 2024 | 939.24 Bn |
| Sep 30, 2024 | 939.24 Bn |
| Jun 30, 2024 | 847,618.00 |
| Jun 30, 2024 | 847,618.00 |
| Mar 31, 2024 | -422,527.00 |
| Mar 31, 2024 | -422,527.00 |
| Dec 31, 2023 | -513.22 Bn |
| Dec 31, 2023 | -513.22 Bn |
| Oct 31, 2023 | -257,878.00 |
| Oct 31, 2023 | -257,878.00 |
| Jul 31, 2023 | -784,047.00 |
| Jul 31, 2023 | -784,047.00 |